Dr. Pervin Topçuoğlu
Kurumu:
Ankara Üniversitesi Tıp Fakültesi Hematoloji BD
Özgeçmiş:
Akademik Çalışmalar:
Yayınlar
A. Uluslararası hakemli dergilerde yayımlanan makaleler :
A1. Üstün C, Beksac M, Dalva K, Koc H, Konuk N, Ilhan O, Ozcan M, Topcuoglu P, Sertkaya D, Hayran M. Invivo use of all-trans retinoic acid (ATRA) prior to induction chemotherapy improves complete remission rate and increases rhodamine123 uptake in patients with de novo acute myeloid leukemia. Medical Oncology 19(1):59-67, 2002 (C grubu-SCI)
A2. Beksac M, Celebi H, Sargın D, Yalcın A, Topcuoglu P, Kalayoglu-Besisik, Beyan C, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H. The role of pretransplant Interferon -alpha treatment on the outcome of stem cell transplantation from related donors in chronic myelogenous leukemia. Bone Marrow Transplantation 31(10):897-904, 2003 (B grubu-SCI)
A3. Topcuoglu P, Arat M, Dalva K, Ozcan M. Administration of granulocyte colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplantation Jan;33(2):171-6, 2004 (B grubu-SCI)
A4. Arat M, Arslan O, Ayyıldız E, Topcuoglu P, Dalva K, Ilhan O. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience. Trans Apher Sci 30(3):189-91, 2004 (C grubu-SCI)
A5. Nurhan N, Yürür-Kutlay N, Topcuoglu P, Saykı M, Gurman G, Tukun A. Translocation (13;17)(q14;q25) as a novel chromosomal abnormality in acute myeloid leukemia-M4. Leukemia Research (Case) 30(7): 903-905, 2006. (C grubu-SCI)
A6. Akar AR, Durdu S, Topcuoglu P. G-CSF in acute myocardial infarction-Experimental and clinical finding/G-CSF in acute myocardial infarction: a word of caution. Anadolu Kardiyol Derg.- The Anatolian Journal of Cardiology (Letter) 6: 390-1, 2006 (C grubu-SCI)
A7. Topcuoglu P, Soydan EA, Ekiz F, Ayyıldız E, Dalva K, Ozcan M, Arslan O, Arat M, Ilhan O. How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight. Transfusion&Apheresis Science. 36: 275-280, 2007. (C grubu-SCI)
A8. Soydan E, Ayyıldız E, Dalva K, Topcuoglu P, Tol M, Arslan O, Ilhan O, Arat M. Impact of harvest product volume in erythroid depletion of allogeneic or autologous bone marrow using COBE spectra. Transfusion&Apheresis Science. 36: 269-273, 2007. (C grubu-SCI)
A9. Ayyildiz E, Arslan O, Topcuoglu P, Arat M, Dalva K, Soydan EA, Tol M, Ilhan O. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD). Transfusion&Apheresis Science. 36: 79-85, 2007. (C grubu-SCI)
A10. Soydan E, Topcuoglu P, Dalva K, Arat M. The impact of methylenetetrahydrafolate reductase (MTHFR) C677T gene polimorphysm on transplant-related variables after allogeneic hematopoietic cell transplantation in patients receiving MTX as GVDH prophylaxis. Bone Marrow Transplant 42, 429-430, 2008. (Letter) (B grubu-SCI)
A.11. Aktas B, Topcuoglu P, Kurt OK, Ensari A, Demirer T. Severe Henoch-Schönlein purpura induced by cytarabine. Ann Pharmacother. 2009 Apr;43(4):792-3. Epub 2009 Mar 31. (B grubu-SCI)
A.12. Ozcelik T, Topcuoglu P, Beksac M, Ozcan M, Arat M, Biyikli Z, Bakanay SM, Ilhan O, Gurman G, Arslan O, Demirer T. Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF. Bone Marrow Transplant. 2009 Dec;44(12):779-83. Epub 2009 Jul 13. (B grubu-SCI)
A13. Ince EU, Ertem M, Ileri T, Dalva K, Topcuoglu P, Uysal Z. Mixed chimerism following hematopoietic stem cell transplantation in pediatric thalasemi majör patients: a singhle center experience. Turk J Hematol. 2010 27:8-14 (C grubu-SCI)
A14. Kurt Yüksel M, Topçuoğlu P, Kurdal M, Ilhan O. The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study. Cytotherapy. 2010;12(1):38-44. (A grubu-SCI)
A15. Akay BN, Sanli H, Topcuoglu P, Arat M, Akyol A. Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy. Br J Dermatol. 2010 May;162(5):1076-82. Epub 2010 Mar 5. (A grubu-SCI)
A16.Kabacam G, Kabacam G, Topcuoglu P, Kuzu I, Arat M. Enzyme replacement therapy in type 1 Gaucher disease and a review of the literature. Turk J Hematol 2010; 27:190-95 (Case report) (C grubu-SCI)
A17. Sarı T, Yüksel MK, Topçuoğlu P, Tol M, Ayyıldız E, Ozcan M, Ilhan O. The effect of CD34 count and clonogenic potential of hematopoietic stem cells on engraftment. Transfus Apher Sci. 2010 Dec;43(3):315-20. Epub 2010 Oct 23. (C grubu-SCI)
A18.Akay BN, Sanli H, Topcuoglu P, Zincircioğlu G, Gurgan C, Heper AO. Black hairy tongue after allogeneic stem cell transplantation: an unrecognized cutaneous presentation of graft-versus-host disease.Transplant Proc. 2010 Dec;42(10):4603-7. (C grubu-SCI)
A19.Sinem Civriz Bozdağ, Gülden Bozkurt, Pervin Topcuoglu, Alpay Azap, Muhit Özcan, Nahide Konuk, Önder Arslan. How Does Influenza A (H1N1) Infection Proceed in Allogeneic Stem Cell Transplantation Recipients? 10.5152/tjh.2011.74 TJH 2012; 29(1):63-66. (C grubu-SCI)
A20. Topcuoglu P, Arat M, Ozcan M, Arslan O, Ilhan O, Beksac M, Gurman G. Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients. Ann Hematol. 2012 Apr;91(4):577-86. Epub 2011 Oct 5. (B grubu-SCI)
A21. Zulfikar B, Aydogan G, Salcioglu Z, Oner AF, Kavakli K, Gursel T, Sayli T, Ozatli D, Dilek I, Buyukkececi F, Omay SB, Ucar C, Çaliskan Ü, Timur C, Dundar S, Kupesiz A, Yesilipek A, Akarsu S, Kurekci E, Atay A, Aydogdu I, Ozcan M, Topcuoglu P, Gurgey A, Ayyildiz O, Soker M, Biner B. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey. Haemophilia. 2012 May;18(3):383-91. doi: 10.1111/j.1365-2516.2011.02693.x. Epub 2011 Nov 22. (A grubu-SCI)
A22. Gürgan C, Ozcan M, Karakuş O, Zincircioğlu G, Arat M, Soydan E, Topcuoglu P, Gürman G, Bostancı H. Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen. Int J Dent Hyg. 2012 Apr 9. doi: 10.1111/j.1601-5037.2012.00550.x.
A23.Tekgündüz E, Altuntaş F, Sıvgın S, Akı SZ, Dönmez A, Topçuoğlu P, Yıldırım R, Baysal NA, Ayyıldız E, Yüksel MK, Sarı I, Tombuloğlu M, Unal A, Ilhan O. Plerixafor use in patients with previous mobilization failure: A multicenter experience. Transfus Apher Sci. 2012 Aug;47(1):77-80. doi: 10.1016/j.transci.2012.05.004. Epub 2012 May 18. (C grubu-SCI)
A24.Civriz Bozdag S, Bay M, Ayyıldız E, Topcuoglu P, Ilhan O. Impact of age and diagnosis on viability during centrifugation and cryopreservation of peripheral blood stem cell products. Transfus Apher Sci. 2012 Aug;47(1):117-20. doi:10.1016 /j.transci. 2012.05.012. Epub 2012 May 19. (C grubu-SCI)
A25.Civriz Bozdag S, Bay M, Ayyıldız E, Topcuoglu P, Ilhan O. Older age and capacity of colony forming unit in autologous peripheral derived hematopoietic cells. Transfus Apher Sci. 2012 Aug;47(1):113-6. doi: 10.1016/j.transci.2012.05.011. Epub 2012 May 24. (C grubu-SCI)
A26.Yüksel MK, Tekgündüz E, Sönmez C, Topcuoglu P, Yurtcu A, Demiriz I, Tetik A, Kayıkçı O, Cınarsoy M, Altuntaş F. A feasible shortcut for the mobilization outcome: Steady state CD34 positive hematopoietic stem cells. Transfus Apher Sci. 2012 Aug;47(1):67-75. doi: 10.1016/j.transci.2012.05.003. Epub 2012 May 31. (C grubu-SCI)
A27.Alpay Azap, Gülden Yılmaz Bozkurt, Meltem Kurt Yüksel, Hakan Kutlu, Pervin Topçuoğlu, Adalet Aypak, Hamdi Akan. Secondary Infections in Cancer Patients with Febrile Neutropenia. 10.5152/tjh.2011.75 TJH 2012; 29(3):254 - 258 (C grubu-SCI)
A28.Selami K. Toprak, Sema Karakuş, Pervin Topçuoğlu. Extramedullary Plasmacytoma Presenting as a Mediastinal Mass: A Comment. 10.5505/tjh.2012.24382 TJH 2012; 29(3): 307 - 308 (C grubu-SCI)
A29. .K. Toprak , S. Ocal , B. Erismis, E. Yildirim, R. Altun, S. Karakus, I. Tek, P. Topcuoglu: Acute Pancreatitis Following VAD Chemotherapy Combination Consisting Of Vincristine, Doxorubicin, And Dexamethasone In A Newly Diagnosed Multiple Myeloma Patient: A Case Report.. The Internet Journal of Oncology. 2012 Volume 8 Number 2. DOI: 10.5580/2b68 .
B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler :
B1. Arat M, Arslan O, Özcan M, Gürman G, Beksac M, Koc H, Ayyildiz E, Topçuoglu P, Dalva K, Akan H, Demirer T, Uysal A, Konuk N, İlhan O. Allogeneic peripheral blood stem cell apheresis: Ibni Sina Experience. XII Congress of The European Society For Haemapheresis, Riva del Garda, Italy, September 16-19, 2001. (Poster)
B2. Ilhan O, Arat M, ARslan O, Dalva K, Bakanay M, Topcuoglu P, Ayyildiz E, Ciftci A, Akan H. The effect of preapheresis dentritic cell counts on the stem cell product. XII Congress of The European Society For Haemapheresis, , Riva del Garda, Italy, September 16-19, 2001. (Poster)
B3. Ozcan M, Erkan E, Arat M, Topcuoglu P, Bozdayı AM, Akan H. The frequency and clinical relevance of hereditary thrombophilia in allogeneic hematopoietic stem cell transplantation recipients XVIII. International Society of Thrombosis and Hemostasis Meeting, Paris, France, 6-12 Temmuz 2001. (Poster)
B4. Arat M, Aydintug S, Gungor ET, Topcuoglu P, Genc V, Erkek B, Akan H. A retrospective comparison of two different nutritional regimens (low vs standard) in hematopoietic stem cell transplantation. 23rd Congress of the European Society of Parenteral and Enteral Nutrition, September, 8-12, 2001, Munich, Germany Clin Nutrition, 20 (suppl 3): 61, 2001. (Sözel)
B5. Ilhan O, Arat M, Dalva K, Arslan O, Bakanay SM, Topcuoglu P, Ayyildiz E, Ciftci A, Akan H. The effect of preapheresis dendritic cell counts on the stem cell product. The effect of preapheresis dentritic cell counts on the stem cell product. IXth International Symposium on Biomedical Science and Technology, 19-22 September, 2002, Antalya, Turkey (Poster)
B6. Yazman D, Dalva K, Topcuoglu P, Soydan E, Baris F, Arat M, Akan H, Beksac M. Presence of CMV DNA in blood is a predictor of shorter survival following both allogeneic bone marrow and peripheral stem cell transplantation. 28th Annual Meeting of European Group for Blood and Marrow Transplantation, 25-28 Mart 2001, Montreux, Switzerland. Bone Marrow Transplantation. 2002, 29 (suppl 2) S:131. (Poster)
B7. Yildirim I, Arslan O, OZer Y, Arat M, Soydan E, Topcuoglu P, Ozcan M, Gurman G, Ilhan O, Koc H, Beksac M, Uysal A, Konuk N, Akan H. The profile of erythrocyte antigens after allogeneic hematopoietic stem cell transplantation. 28th Annual Meeting of European Group for Blood and Marrow Transplantation, 25-28 Mart 2001, Montreux, Switzerland. Bone Marrow Transplantation. 2002, 29 (suppl 2) S:239. (Poster)
B8. Tavat C, Arslan O, Arat M, Ilhan O, Topcuoglu P, Beksac M, Akan H. Is there a correlation between peripheral blood CD34+ cells and peripheral blood erythrocyte precursors in healthy G-CSF stimulated donors and the effect of G-CSF and apheresis on complete blood count. 28th Annual Meeting of European Group for Blood and Marrow Transplantation, 25-28 Mart 2001, Montreux, Switzerland. Bone Marrow Transplantation, 2002, 29 (suppl 2) S:236. (Poster)
B9. Ozcan M, Topcuoglu P, Arat M, Dalva K, Soydan E, Arslan O, Ilhan O. Presence of tissue factor (TF) antigen expressing cells within allogeneic peripheral blood progenitor cell (PBPC) harvest. 28th Annual Meeting of European Group for Blood and Marrow Transplantation, 25-28 Mart 2001, Montreux, Switzerland. Bone Marrow Transplantation, 2002, 29 (suppl 2) S:236. (Poster)
B10. Yazman D, Topcuoglu P, Arat M, Kurt M, Ozcan M. Thromboembolic complication after allogeneic hematopoietic cell transplantation: The Ibni Sina Experience. 28th Annual Meeting of European Group for Blood and Marrow Transplantation, 25-28 Mart 2001, Montreux, Switzerland. Bone Marrow Transplantation, 29 (suppl 2) S:215, 2002. (Poster)
B11. Arslan O, Arat M, Soydan E, Coskun HS, Topcuoglu P, Ozcan M, Gurman G, Demirer T, Ilhan O, Koc H, Beksac M, Konuk N, Uysal A, Akan H. Does donor ABO-incompatibility have any effect on the course and outcome of allogeneic hematopoietic cell transplantation. 28th Annual Meeting of European Group for Blood and Marrow Transplantation, 25-28 Mart 2001, Montreux, Switzerland. Bone Marrow Transplantation, 29 (suppl 2) S:214, 2002. (Poster)
B12. Arat M, Topcuoglu P, Soydan E, Gurman G, Ozcan M, Arslan O, Koc H, Konuk N, Uysal A, Beksac M. A retrospective comprasion of oral versus intravenous administration of Busulfan: Preliminary results show similar toxicity but less relapse. 28th Annual Meeting of European Group for Blood and Marrow Transplantation, 25-28 Mart 2001, Montreux, Switzerland. Bone Marrow Transplantation 29 (suppl 2) S:178, 2002. (Poster)
B13. Yuksel MK, Arat M, Ilhan O, Topcuoglu P, Soydan E, Beksac M, Ozcan M, Arslan O, Gurman G, Konuk N, Uysal A, Akan H. Retrospective clinical and pathological analysis of 86 patients diagnosed primary myelodysplastic syndrome (MDS): Bournemouth Scoring System and Overal Survival. 8th Annual Congress of The European Hematology Association, 12-13 June, 2003, Lyon, France. Hematol J, 4(Supl 2): 217, 2003. (Poster)
B14. Arat M, Arslan O, Ozcan M, Gurman G, Beksac M, Koc H, Ayyildiz E, Topcuoglu P, Dalva K, Akan H, Demirer T, Uysal A, Konuk N, Ilhan O. Content of stem cells collected from healthy donors for allogeneic transplantation: Excess CD3 hazard. 9th Congress of the World Apheresis Association, Paris, France Abstract book.62, 7-10 September, 2002. (Poster)
B15. Topcuoglu P, Ozcan M, Dalva K, Arat M. The administration of rhG-CSF to healthy donors for peripheral blood progenitor cell collection may induce the tissue factor dependent pathway. 9th Congress of the World Apheresis Association, Paris, France. Abstract book.39, 7-10 September, 2002. (Sözel)
B16. Yuksel MK, Arat M, Ayyildiz E, Topcuoglu P, Soydan E, Arslan O, Ozcan M, Beksac M, Gurman G, Konuk N, Uysal A, Ilhan O. Efficacy of cytoreductive leukopheresis in acute leukemia patients with hyperleukocytosis. ESFH 14th Congress of the Interdiciplinary European Society for Haemepheresis and haemotherapy. September 10-13, 2003, Praque. Abstract book.14. (Sözel)
B17. Matrak M, Sen R, Yanik A, Ender H, Soydan E, Topcuoglu P, Ozcan M, Akan H
Grading oral mucositis using World Health Organization and National Cancer Institute scoring systems. 29th Annual Meeting of European Group for Blood and Marrow Transplantation, 23-26 March 2003, Istanbul, Turkey. Bone Marrow Transpl 31: S268 Suppl. 2003. (Sözel)
B18. Ozcan M, Topcuoglu P, Beksac M, Dalva K The relation between T-helper subsets and the risk of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. 29th Annual Meeting of European Group for Blood and Marrow Transplantation, 23-26 March 2003, Istanbul, Turkey. Bone Marrow Transpl. 31: S17 Suppl. 2003. (sözel)
B19. Arat M, Topcuoglu P, Soydan EA, Gurman G, Ozcan M, Arslan O, Koc H, Ilhan O, Konuk N, Uysal A, Akan H, Beksac M A retrospective comparison of oral versus intravenous administration of busulfan. 29th Annual Meeting of European Group for Blood and Marrow Transplantation, 23-26 March 2003, Istanbul, Turkey. Bone Marrow Transpl 31: S20 Suppl. 2003. (sözel)
B20. Ozcan M, Topcuoglu P, Arat M, Soydan EA, Erkan O, Akan H. The presence of hereditary thrombophilia may increase the risk of thrombotic complications after allogeneic hematopoietic cell transplantation. 29th Annual Meeting of European Group for Blood and Marrow Transplantation, 23-26 March 2003, Istanbul, Turkey. Bone Marrow Transpl 31: S112-S113 Suppl. 2003. (Poster)
B21. Soydan EA, Arat M, Topcuoglu P, Ozcan M, Arslan O, Idilman R, Gurman G, Beksac M, Akan H, Ilhan O. The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft-versus-host disease. 29th Annual Meeting of European Group for Blood and Marrow Transplantation, 23-26 March 2003, Istanbul, Turkey. Bone Marrow Transpl 31: S135-S136 Suppl. 2003. (Poster)
B22. Gürman G, Arat M, Topcuoglu P, Soydan EA, Beksac S, Ozcan M, Konuk N, Uysal A, Koc H, Arslan O, Akan H, Ilhan O. Case-controlled comparative analysis of ablative and reduced-intensity allogeneic haematopoietic stem cell transplantation in standard risk CML. 30th Annual Meeting of European Group for Blood and Marrow Transplantation, 29-31 March 2004, Barcelona, Spain. Bone Marrow Transplant 33 (Suppl. 1): S108-109, 2004. (Poster)
B23. Topcuoglu P, Arat M, Bulakbasi T, Soydan E, Ozer Y, Arslan O. The comparison of two different conditioning regimens, myeloablative versus reduced intensive, in ABO mismatched allogeneic hematopoietic stem cell transplantation. 30th Annual Meeting of European Group for Blood and Marrow Transplantation, 29-31 March 2004, Barcelona, Spain. Bone Marrow Transplant 33 (Suppl. 1): S109-110, 2004. (Poster)
B24. Soydan EA, Arat M, Bulakbasi T, Topcuoglu P, Arslan O, Ozcan M, Gurman G, Beksac M, Akan H, Ilhan O. The outcome of patients with an identified HLA identical sibling donor: impact of transplantation rate on early transplant outcome. 30th Annual Meeting of European Group for Blood and Marrow Transplantation, 29-31 March 2004, Barcelona, Spain. Bone Marrow Transplant 33 (Suppl. 1): S135, 2004. (Poster)
B25. Topcuoglu P, Zaucha JM, Arat M, Akan H, Gozdzik J, Szatkowski D, Hellmann A, Beksac M. Factors influencing the outcome of HLA-identical sibling transplants for chronic myeloid leukaemia: collaborative analysis from three centres in Poland and Turkey. 30th Annual Meeting of European Group for Blood and Marrow Transplantation, 29-31 March 2004, Barcelona, Spain.Bone Marrow Transplant 33 (Suppl. 1): S152, 2004. (Poster)
B26. Beksac M, Soydan E, Arat M, Topcuoglu P, Yuksel MK, Toprak SK, Kizil M, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H. High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre. 30th Annual Meeting of European Group for Blood and Marrow Transplantation, 29-31 March 2004, Barcelona, Spain. Bone Marrow Transplant 2004; 33 (Suppl. 1): S163.
B27. Arat M, Soydan EA, Topcuoglu P, Aktas B, Beksac M. Does donor/recipient parity have any impact on graft-versus-host disease? The results of a single-centre retrospective multivariate analysis. 30th Annual Meeting of European Group for Blood and Marrow Transplantation, 29-31 March 2004, Barcelona, Spain. Bone Marrow Transplant 2004; 33 (Suppl. 1): S175. (Poster)
B28. Topcuoglu P, Arat M, Soydan E, Dalva K, Ciftcioglu A, Akan H, Ilhan O, Beksac M. Occurrence of Cytomegalovirus infection and/or viraemia shortens overall survival. 30th Annual Meeting of European Group for Blood and Marrow Transplantation, 29-31 March 2004, Barcelona, Spain. Bone Marrow Transplant 2004; 33 (Suppl. 1): S203-204. (Poster)
B29. Ayyildiz E, Topcuoglu P, Dalva K, Soydan EA, Tol M, Arat M, Ilhan O, Arslan O. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a levels in chronic graft versus host disease). XXXth World Congress of the International Society of Hematology, September 28-October 2, 2005. Turkish J Hematol 22 (suppl 1) 2005: 310(775). (Poster)
B30. Ilhan O, Topcuoglu P, Arat M, Soydan EA, Yuksel MK, Toprak SK, Arslan O, Ozcan M, Gürman G, Demirer T, Akan H, Beksac M, Konuk N, Uysal A, Koc H. Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia. Ankara University Experience. XXXth World Congress of the International Society of Hematology, September 28-October 2, 2005. Turkish J Hematol 22 (suppl 1) 2005. 277 (672). (Poster)
B31. Topcuoglu P, Ekiz F, Soydan EA, Yuksel MK, Toprak SK, Ozcan M, Arslan O, Gürman G, Demirer T, Akan H, Beksac M, Uysal A, Konuk N, Arat M, Ilhan O. How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight. XXXth World Congress of the International Society of Hematology, September 28-October 2, 2005. Turkish J Hematol 22 (suppl 1) 275 (575), 2005. (Poster)
B32. Ozcan M, Yüksel MK, Topçuoğlu P, Soydan EA, Toprak SK, Beksac M, Uysal A, Akan H, Demirer T, Arslan O, Arat M, Ilhan O. Addition of the anti-CD20 to high dose chemotherapy with autologous peripheral stem cell transplantation (Auto-PSCT) prolong disease-free survival (DFS) in Non-Hodgkin’s Lymphomas: A matched-controlled analysis. XXXth World Congress of the International Society of Hematology, September 28-October 2, 2005. Turkish J Hematol 22 (suppl 1) 242(573), 2005. (Poster)
B33. Azap A, Ceydilek B, Bektas M, Yagcı D, Topçuoglu P, Kurt H, Akan H. Is BWT a predictor of mortaility in NEC patients? Analysis of 20 patients with neutropenic enterecolitis. XXXth World Congress of the International Society of Hematology, September 28-October 2, 2005. Turkish J Hematol 22 (suppl 1) 208(485), 2005. (Poster)
B34. Arat M, Topcuoglu P, Yüksel MK, Dalva K, Akar G, Gurman G, Arslan O, Ozcan M, Beksac M, Konuk N, Uysal A, Koc H, Ilhan O. A new predictive and prognostic marker for de novo AML: Peripheral blood CD34 count at recovery following remission induction therapy. XXXth World Congress of the International Society of Hematology, September 28-October 2, 2005. Turkish J Hematol 22 (suppl 1) 118(233), 2005. (Poster)
B35. Durdu S, Akar R, Arat M, Sancak S, Ozçınar E, Topcuoğlu P, Arslan Ö, Bülent Kaya, Tümer Çorapçıoğlu, İlhan O; Ümit Özyurda. Postnatal neovascularization with implantataion of autologous bone marrow mononuclear cells for patients with Rutherford grade II/III thromboangiitis obliterans XXXth World Congress of the International Society of Hematology, September 28-October 2, 2005. Turkish J Hematol 22 (suppl 1) 96(180), 2005. (Sözel).
B36. Soydan E, Topcuoglu P, Ozcan M, Arslan O, Gurman G, Arat M, Ilhan O. The impact of methylenetetrahydrofolate reductase C677T gene polymorphism on engraftment after allogeneic hematopoetic cell transplantation in patients receiving methotrexate in graft versus host disease prophylaxis. XXXth World Congress of the International Society of Hematology, September 28-October 2, 2005. Turkish J Hematol 22 (suppl 1) 75(132), 2005. (Sözel)
B37. Bulakbasi T, Toprak SK, Iyidir OT, Sonyurak P, Altan M, Soydan E, Yuksel MK, Topcuoglu P, Arat M, Ilhan O. The use of subjective global assessment in determining the nutitional status of hematologic malignancies. XXXth World Congress of the International Society of Hematology, September 28-October 2, 2005. Turkish J Hematol 22 (suppl 1) 328 (804), 2005. (Poster)
B38. Topcuoglu P, Bulakbasi T, Soydan EA, Arat M, Akan H, Arslan O. The comparison of the impact of ablative vs reduced intensity conditioning regimens on the erythrocyte recovery and the early transplant outcome in patients allografted from an ABO incompatible donor. 15th Congress of the Interdisciplinary European Society for Haemapheresis and Haemotherapy and 2nd National Congress of Haemapheresis, October 05-09, 2005, Antalya, Turkey. Transfusion&Apheresis Science 33: 227, 2005. (Sözel).
B39. Topcuoglu P, Demirer T, Arat M, Arslan O, Toprak SK, Yuksel M, Soydan EA, Ilhan O. When to start G-CSF after mobilization regimen? Any impact on stem cell collection efficiency. 15th Congress of the Interdisciplinary European Society for Haemapheresis and Haemotherapy and 2nd National Congress of Haemapheresis, October 05-09, 2005, Antalya, Turkey. Transfusion&Apheresis Science 33: 231, 2005. (Sözel)
B40. Bay M, Akar R, Durdu S, Ayyıldız E, Topcuoglu P, Soydan E, Arat M, Arslan O, Ilhan O. The effect of Needle Diameter on Hematopoietic Stem Cell Viability in Hematopoietic Stem Cell Application (Exvivo Experimental Study). 1st Balkan Hematology Days, 10-11 November 2006. Turk J Hematol (Suppl 2) 23(3):125, 2006. (Poster)
B41. Serbest E, Topcuoglu P, Dalva K, Soydan EA, Arslan O, Ozcan M, Demirer T, Akan H, Konuk N, Uysal A, İlhan O, Gurman G, Beksac M, Arat M. The impact of disparity in short tandem repeats analysis on the outcome of allogeneic hematopoetic cell transplantation from HLA-identical sibling donors. 33rd Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 39 (suppl 1):S197, 2007. (Poster)
B42. Ilhan O, Topcuoglu P, Ayyıldız E, Ozcan M, Soydan EA, Ozcan M, Arat M, Arslan O. Is there any benefit of secondary approaches for stem cell (auto-PBSC) collection in poor mobilizing myeloma and lymphoma patients. 33rd Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. Bone Marrow Transplant. 39 (suppl 1):S134, 2007. (Poster)
B43. Soydan EA, Cengiz G, Şanli HE, Topçuoglu P, Bilgin AU, Bakanay SM, Arslan O, Ozcan M, Demirer T, Akan H, Ilhan O, Beksac M, Konuk N, Uysal A, Gurman G; Arat M. The impact of histopathological subtype of cutaneous chronic GvHD on alloHSCT outcome: lichenoid versus sclerodermoid. 33rd Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. Bone Marrow Transplant 2007; 39 (suppl 1):S106, 2007. (Poster)
B44. Bozdag SC, Soydan EA, Topçuoglu P, Bilgin AU, Bakanay SM, Koc H, Beksac M, Ilhan O, Ozcan M, Gurman G, Arat M. Treatment of relapse after allogeneic stem cell transplantation in CML patients: imatinib only versus imatinib&DLI. 33rd Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 39 (suppl 1):S70, 2007. (Poster)
B45. Bilgin AU, Soydan EA, Topcuoglu P, Gunaydın Y, Uysal A, Konuk N, Beksac M, Akan H, Gurman G, Ozcan M, Arslan O, Demirer T, Ilhan O, Arat M. The impact of pretransplant imatinib use in allogeneic hematopoetic cell transplantation for CML: a single centre comparative analysis. 33rd Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 39 (suppl 1):S68, 2007. (Poster)
B46. Gurman G, Arat M, Topcuoglu P, Soydan EA, Arslan O, Ozcan M, Akan H, Beksac M, Konuk N, Uysal A, Koc H, Ilhan O. Case-matched comparison for analyzing the impact of regimen intensity of allogeneic hematopoetic cell transplantation in chronic myeloid leukemia. 33rd Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 39 (suppl 1):S39, 2007. (Sözel)
B47. Kabacam G, Soydan EA, Topcuoglu P, Dalva K, Ozdemir P, Ozcan M. Relationship between the mucositis seen after the allogeneic hematopoetic stem cell transplantation and the human leukocyte antigen types. 33rd Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 39 (suppl 1):S209, 2007. (Poster)
B48. Topçuoglu P, Dalva K, Meric S, Sahin S, Arat M, Beksac M. The determination of leukemic phenotype and minimal residual disease in acute myeloid leukemia by using flow cytometry. 12th Congress of the European Hematology Association Vienna, Austria, June 7-10, 2007. Haematologica 92 (Suppl 1): 19, 2007. (Poster)
B49. Bilgin AU, Topçuoglu P, Soydan E, Aktas B, Kumbasar O, Azap A, Akan H, Arat M. Is there any effect of invasive fungal infection on the outcome of hematopoetic stem cell transplantation. 12th Congress of the European Hematology Association Vienna, Austria, June 7-10, 2007. Haematologica 92 (Suppl 1): 390, 2007. (Abstract)
B50. Topcuoglu P, Gunaltay S, Dlava K, Bilgin AU, Arat M, Gurman G, Ozcan M. The presence of thrombophilia and the development of thromboembolic complications in allogeneic haematopoietic cell transplantation. 34th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 41(Supp 1): S70, 2008 (Sözel)
B51. Serbest E, Topcuoglu P, Dalva K, Bilgin AUi Soydan E, Ozcan M, Arslan O, Ilhan O, Beksac M, Gurman G, Arat M. The relation between the disparities of short tandem repeats between donor-recipient pair and the allogeneic haematopoietic cell transplantation outcome. 34th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 41(Supp 1): S82, 2008 (Poster)
B52. Beksac M, Bilgin AU, Akcaglayan S, Ozkocaman V, Topcuoglu P, Evranos B, Kizil M, Arat M, Arslan O, Ozcan M, Gurman G, Ilhan O. Response to induction, early mobilization and pre-autologous transplant use of bortezomib and/or thalidomide prolong progression free and/or overall survival in myeloma. 34th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 41(Supp 1): S186, 2008 (Poster)
B53. Topcuoglu P, Bilgin AU, Ayyildiz E, Dalva K, Arslan O, Ilhan O, Beksac M, Arat M, Ozcan M. So the febrile neutropenic episodes during mobilization have any effect on autologous stem cell collection yield in patients with myeloma and lymphoma?. 34th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 41(Supp 1): S269, 2008 (Poster)
B54. Bozdağ SC, Bakanay SM, Topçuoğlu P, Arat M, Özcan M, Beksaç M, Gürman G, Arslan Ö. Allogeneic stem cell transplantation for Hodgkin’s Lymphoma. Second International Congress on Leukemia, Lymphoma, Myeloma, 21-24 May 2009, Istanbul, Turkey. (Poster)
B55. Topcuoglu P, Kumbasar OO, Arslan O, Ozcan M, Ilhan O, Akan H, Beksac M, Konuk N, Gurman G, Arat M. Bronchiolitis obliterans after allogeneic hematopoietic cell transplantation: impredicatable and fatal. 36th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 45(Supp 2): S99, 2010 (Poster)
B56. Akay BN, Sanlı H, Topcuoglu P, Arat M, Gurman G, Akyol A. The handeled dermatoscope as a nail-fold capillaroscopic instrument in sclerodermoid graft versus host disease. 36th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 45(Supp 2): S137, 2010 (Poster)
B57. Bakanay SM, Arat M, Serbest E, Topcuoglu P, Soydan EA, Bilgin AU, Bozdag SC, Dalva K, Gurman G. Significan of serial chimerism analysis in allogeneic haematopoietic cell transplantation for bone marrow failure: do stable mixed chimerism matter? 36th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 45(Supp 2): S70, 2010 (Poster)
B58. Bozdag SC, Topcuoglu P, Bakanay M, Arat M, Soydan E, Ozcan M, Ilhan O, Demirer T, Beksac M, Arslan O, Konuk N, Uysal A, Gurman G. Omparison of two different chemotherapy regiems for peripheral blood stem cell mobilization in lymphoma. 36th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 45(Supp 2): S257, 2010 (Poster)
B59. Topcuoglu P, Soydan E, İdilman R, Ustun C, Arslan O, Ozcan M, Ilhan O, Beksac M, Arat M, Gurman G. Allogeneic haematopoetic cell transplantation in hepatitis B surface antigen positive recipients. 36th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 45(Supp 2): S223, 2010 (Poster)
B.60. Topcuoglu P, Arat M, Soydan E, Arslan M, Ozcan M, Ilhan O, Akan H, Beksac M, Konuk N, Uysal A, Gurman G. Long-term outcome in patiets surviving 5 or more years after allogeneic haematopoetic cell transplantation. 37th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 46(Supp 1): S165-166, 2011 (Poster)
B61. Yılmaz Bozkurt G, Civriz Bozdag S, Topcuoglu P, Azap A, Arat M, Beksac M, Ilhan O, Ozcan O, Arslan O, Gurman G. Invasive fungal infections during a construction period. 37th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 46(Supp 1): S232, 2011 (Poster)
B62. Bakanay SM, Ayyildiz E, Arat M, Topcuoglu P, Soydan E, Dalva K, Bozdağ SC, Demir F, Demirer T, Arslan O, Ozcan M, Gurman G, Beksac M, Ilhan O. Peripheral stem cell aphersis in multiple myeloma in the era of new agents. 37th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 46(Supp 1): S261-262, 2011 (Poster)
B63. Topcuoglu P, Bozdag SC, Bakanay SM, Arat M, Ozcan M, Akan H, Ilhan O, Beksac M, Gurman G. The role of second allogeneic hematopoietic cell transplantation on relapse of haematological disease. 37th Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 46(Supp 1): S280-281, 2011 (Poster)
B64. İlhan O, Bay M, Ayyildiz E, Kaplan N, Topcuoglu P. Older age and Capacity of Colony Forming Unit (CFU) in Autologous Peripheral Derived Hematopoietic Cells. ISCT 2011 Annual Meeting Abstracts. Cytotherapy 13 (Supp):127, 2011 (Poster)
B65. İlhan O, Bay M, Ekicis S, Ayyildiz E, Topcuoglu P. Impact of Centrifugation and Cryopreservation on Peripheral Blood (PB) Derived Stem and Progenitor Cells (HSPCS) Viability. ISCT 2011 Annual Meeting Abstracts. Cytotherapy 13 (Supp):128, 2011 (Poster)
B66. Öztürk Özbilgin M, Belder N,Küçük NÖ, Topçuoğlu P, Özcan M, Kuzu I, Özdağ H. Molecular gene profiling for the treatment of diffuse large B cell lymphoma in Turkish Population. 3rd International Congress on Leukemia, Lymphoma, Myeloma, 11-14 May 2011, Istanbul, Turkey. (Poster)
B67. Bozdağ SC, Kuzu M, Arat M, Topçuoğlu P. The development of acute lyphoblastic leukemia in a patient with Gaucher disease after enzyme replacement therapy. 3rd International Congress on Leukemia, Lymphoma, Myeloma, 11-14 May 2011, Istanbul, Turkey. (Poster)
B68. Bozdağ SC, Başlar S, Kuzu I, Kaygusuz G, Topçuoğlu P. Disseminated intravascular coagulation in T cell large granular lymphoma. International Congress on Leukemia, Lymphoma, Myeloma, 11-14 May 2011, Istanbul, Turkey. (Poster)
B69. Bozdağ SC, Bakanay SM, Topçuoğlu P, Arslan Ö, Beksaç M, Konuk N, Gürman G, Özcan M. Comparison of two different induction regimen in acute lymphoblastic leukemia. International Congress on Leukemia, Lymphoma, Myeloma, 11-14 May 2011, Istanbul, Turkey. (Poster)
B70-Topcuoglu, P, Baslar, S, Bozdag, S. C.Dalva K, Ayyildiz E, Uysal A, Gurman G, Ozcan M. The effect of cyclophosphamide with bortezomib as the mobilisation regimen on the graft quality and response of disease in multiple myeloma. BONE MARROW TRANSPLANTATION Volume: 47 Supplement: 1 Pages: S244-S245 Published: APR 2012. 38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) Location: Geneva, SWITZERLAND Date: APR 01-04, 2012 (Poster)
B71-Toprak S, Topcuoglu P, Arslan O, Ilhan O, Akan H, Gurman G, Ozcan M. Oral cavity chronic-graft-versus host disease after allogeneic haematopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION Volume: 47 Supplement: 1 Pages: S343-S343 Published: APR 2012. 38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) Location: Geneva, SWITZERLAND Date: APR 01-04, 2012
B72- Atilla E, Topcuoglu P, Yavasoğlu S, Karakaya A, Gencturk c; Bozdag S, Arslan O. A RANDOMIZED COMPARISON OF HEMOGLOBIN CONTENT-BASED VS STANDARD (UNIT-BASED) RBC TRANSFUSION POLICY EFFICIENCIES. VOX SANGUINIS Volume: 101 Special Issue: SI Supplement: 2 Pages: 121-121 Published: DEC 2011 (Poster)
C. Ulusal hakemli dergilerde yayımlanan makaleler :
C1. Cesur S, Topcuoglu P, Asık O, Birengel S, Ozcan M. Acute Hepatic Failure in a Case of Acute Lymphoblastic Leukemia. Turk J Med Sci, (Vaka) 34: 275-279, 2004.
C2. Azap A, Topcuoglu P, Yesilkaya A, Arat M, Memikoglu O, Akan O, Kurt H, Tekeli E, Akan M. The effect of a nationwide antibiotic restriction policy on antibiotic usage in a stem cell transplantation unit. Turk J Haematol 22(2): 87-90, 2005. (Tam metin-klinik araştırma)
C3. Topcuoglu P, Arat M. Kronik Miyelositer Lösemide imatinib Direnci ve Tedavi Seçenekleri. Turkiye Klinikleri J Int Med Sci 3(2):62-73, 2007. (Derleme)
C4. Ozcan M, Topcuoglu P. Kronik lenfositik lösemi ve lenfositik lenfoma. Türkiye Klinikleri J Int Med Sci. (Derleme). 3(19): 32-42, 2007 (Derleme)
C5. Topcuoglu P, Bakanay SM, Dalva K, Arat M, Beksaç M, Özcan M. T-helper-1 (Th1) and Th2 Cytokines after allogeneic hematopoietic stem cell transplantation (Allo-HSCT). Turk J Haematol 25(1), 2008. (Tam metin-klinik ve laboratuar araştırma) (TUBİTAK projesi)
C6. Topcuoglu P, Arslan Ö. Proteozom inhibitörleri ve kullanımı. Türkiye Klinikleri Hem-Onc Special Topics 1(1): 45-53, 2008. (Derleme)
C7.Topçuoğlu P, Özcan M. Gebelik ve Kan Hastalıkları. Klinik Gelişim 21(1): 111-127. (Derleme)
C8. İlhan O, Topçuoğlu P, Arat M, Soydan EA, Yüksel MK, Arslan Ö, Özcan M, Gürman G, Demirer T, Akan H, Konuk N, Uysal A. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloblastic leukemia (AML): A single center experience. Turk J Haematol 25(2): 87-93, 2008. (Tam metin-Klinik araştırma)
C9. Şule Mine Bakanay, Pervin Topçuoglu, Aynur Uğur Bilgin, Kanay Yararbaş, Sibel Berker Karaüzüm, Muhit Özcan, Mutlu Arat, Levent Ündar, Osman Ilhan. Clonal evaluation of monosomy 7 in acquired severe aplastic anemia: Two cases treated with allogeneic hematopoietic stem cell transplantation. Turk J Haematol 25(2): 94-97, 2008. (Tam metin-Klinik araştırma)
D. Ulusal bilimsel toplantılarda sunulan ve bildiri kitaplarında basılan bildiriler:
D1. Soydan E, Anadol R, Arat M, Yazman D, Topçuoğlu P. B hücreli kronik lenfositik lösemili bir hastada klasik tip Kaposi sarkomu. XXVIII. Ulusal Hematoloji Kongresi, 1-4 Kasım 1999, Efes Oteli, İzmir. 121 (P-098), 2000. (Poster)
D2. Öztaş E, Arat M, Topçuoğlu P, Soydan E, Yazman D, Koç E. Kemik iliği biyopsisi işleminde iki farklı teknik yaklaşımın karşılaştırılması. XXVIII. Ulusal Hematoloji Kongresi, 1-4 Kasım 1999, Efes Oteli, İzmir. 257 (P-233), 2000. (Poster)
D3. Yazman D, Soydan E, Topcuoglu P, Ilhan O. Hipereozinofilik sendromu taklit eden fasciola hepatica infestasyonu. XXVIII. Ulusal Hematoloji Kongresi, 1-4 Kasım 1999, Efes Oteli, İzmir. 119 (P-096), 2000. (Poster)
D4. Topcuoglu P, Ozcan M, Dalva K, Arat M. Allojeneik kök hücre vericilerinde rhG-CSF kullanımının doku faktörü yoluna Ulusal Hematoloji Kongresi, 1-4 Kasım 1999, Efes Oteli, İzmir. 290 (P-266), 2000. etkisi (Sözlü)
D5. Soydan E, Arat M, Yazman D, Topçuoğlu P, Özcan M, Akan H. Allojeneik hematopoietik hücre naklinde ortaya çıkan tromboembolik komplikasyonlar. Tromboz, Hemostaz ve Anjioloji. 2.Ulusal Tromboz, Hemostaz ve Anjiyoloji Kongresi, 7-8 Kasım 2001, İstanbul, sayfa 101-108, 2001. (Sözel)
D6. Matrak M, Şen R, Yanık A, Ender H, Soydan E, Topcuoglu P, Ozcan M, Akan H. Oral mukozitin Dünya Sağlık Örgütü (WHO) ve National Cancer Institute (NCI) skorlama yöntemleriyle karşılaştırılması. 4.Ulusal İç Hastalıkları Kongresi, 25-29 Eylül 2002, Antalya. S188 (HP14), 2002. (poster)
D7. Arat M, Soydan E, Sancak T, Topçuoğlu P, Ünal E, Demirer S, Akan H. Hematolojik maligniteli hastalarda yarı kalıcı Hickman tipi tünelli santral venöz kateter takılması: İnvasiv radyoloji ile cerrahi yaklaşım karşılaştırılması. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 19: p168, 2002. (Poster)
D8. Yüksel MK, Arat M, Topçuoğlu P, Yazman D, Ayyıldız E, Arslan Ö, Özcan M, Beksaç M, Gürman G. Akut Lösemilerde hiperlökositoz olgularında lökaferezin sitoredüksiyon etkinliği. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 19: p170, 2002. (Poster)
D9. Arat M, İdilman R, Soydan E, Törüner M, Soykan İ, Topcuoğlu P, Özcan M, Erden E, Arslan Ö, Tek İ, Karayalçın S, Özden A, Akan H. Karaciğere sınırlı kronik graft-versus host hastalığı tedavisinde uzun süreli ursodeoksikolik asit tedavinin etkinliği. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 2002; 19: p147, 2002. (Poster)
D10. Arat M, Topcuoglu P, Dalva K, Yüksel MK, Soydan E, Yazman D, Dalva K, Akan H. Akut miyeloblastik lösemide indüksiyon sonrası toparlanma döneminde perifer CD34 düzeyinin prognostic önemi: Bir pilot çalışma. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 19: p129, 2002. (Poster)
D11. Dalva K, Civriz S, Topcuoglu P, Akan H. Akut miyeloblastik lösemide (AML) bir protoonkogen c-kit tirozin kinaz reseptör (CD117) ifade sıklığı. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 19: p128, 2002. (Poster)
D12. Topcuoglu P, Yazman D, Arat M, Koç H, Uysal A, İlhan O. Denovo akut miyeloblastik lösemide Philedalphia kromozumu pozitifliği. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 19: p116, 2002. (Poster)
D13. Kasapoğlu A, Topçuoğlu P, Arslan Ö, Özcan M. Aktive protein C rezistansının ABO kan gruplarıyla ilişkisi. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 19: p109, 2002. (Poster)
D14. İdilman R; Arat M, Tükün A; Erden E, Soydan E, Topçuoğlu P, Kuzu I, Soykan İ, Törüner M, Karayalçın S. Hematopoetik kök hücre nakli sonrası donor kaynaklı hücrelerin alıcı karaciğerinde endotelyal repopulasyonu. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 19: p70, 2002. (Sözel)
D15. Soydan EA, Arat M, Topçuoğlu P, Özcan M, Arslan Ö, İdilman R, Gürman G, Beksaç M, Akan H, İlhan O. Allojeneik hematopoetik kök hücre transplantasyonu sonrası görülen steroide refrakter veya bağımlı kronik graft versus host hastalığının tedavisinde mikofenolat mofetilin etkinliği. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 19: p70, 2002. (Sözel)
D16. Yıldırım İ, Arslan Ö, Özer Y, Arat A, Soydan E, Topçuoğlu P, Akan H. Allojeneik hematopoetik kök hücre transplantasyonu sonrası eritrosit antijenelrinin profili. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 19: p69, 2002. (Sözel)
D17. Soydan E, Akan H, Arat M, İdilman R, Üstün C, Özcan M, Arslan Ö, Topcuoğlu P, Karayalçın S, Beksaç M, İlhan O. Hematopoetik kök hücre vercisinin Hepatit B virus statusun transplantasyon sonrası alıcıda Hepatit B virus seyrine etkisi. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 2002; 19: p66. (Sözel)
D18. İdilman R, Arat M, Soydan E, Törüner M, Beksaç M, Özcan M, Akbulut H, Soykan İ, Arslan Ö, Topçuoğlu P, Karayalçın S, Özden A, İlhan O, Akan H. Hematolojik malignitesi olan Hepatit B virus taşıyıcılarında kemoterapi sırasında lamivudine proflaksisinin etkinliği. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 2002; 19: p66. (Sözel)
D19. Toprak SK, Dalva K, Gültekin G, Topçuoğlu P, Beksaç M. Hematolojik malign hastalıkların biyolojisinde hücre siklusunu düzenleyen siklinlerin rolünün araştırılması XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 2002; 19: p58. (Sözel) (TÜBİTAK projesi, no: SBAG-2205).
D20. Topçuoğlu P, Arat M, Özcan M, Arslan Ö, Gürman G, Beksaç M, İlhan O, Konuk N, Uysal A, Akan H.. Remisyon indüksiyon, konsolidasyon ve yüksek doz sitozin arabinozid içeren rejimlerle tedavi edilen de novo akut myelositer lösemili (AML) olgularda maliyet analizi. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 2002; 19: p38. (Sözel)
D21. Soydan E, Arat M, Topcuoglu P, Demirer T, Arslan Ö, Özcan M, Beksaç M, Gürman G, İlhan O, Konuk N, Koç N, Uysal A, Akan H. Malign lenfomaların otolog kök hücre desteğinde yüksek doz tedavisinde kullanılan 3 rejimin karşılaştırılması: CBV-ICE-CTM. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 2002; 19: p47. (Sözel)
D22. Arat M, Topçuoğlu P, Gürman G, Soydan E, Matrak M, Ender H, Özcan M, Arslan Ö, İlhan O, Akan H, Beksaç M. Busulfanın oral ve parenteral formulasyonunun retrospektif karşılaştırılması. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 2002; 19: p43. (Sözel)
D23. Özcan M, Topçuoğlu P, Beksaç M, Dalva K. Allojeneik kök hücre transplantasyonu sonrası intrasellüler sitokin ölçümü aracılığıyla belirlenen th1/th2 alt gruplarının graft versus host hastalığı ile ilişkisi. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 2002; 19:41. (Sözel)
D24. Yazman D, Dalva K, Yazman M, Beksaç M, Topçuoğlu P, Gürman G. Allojeneik hematopoetik jücre transplantasyonu yapılan hastalar ile vericileri arasındaki minör histokompatibilite antijeni (HA-1) taşımadaki farklılığın engrafman, graft versus host hastalığı ve diğer transplantla ilşkili komplikasyonlara etkisi. XXIX. Ulusal Hematoloji Kongresi, 25-28 Ekim 2002, Antalya. Turk J Haematol 19: p149, 2002. (Poster)
D25. Arat M, Soydan E, Yüksel MK, Topçuoğlu P, Akan H. Myeloablatif olmayan hazırlık rejimi alan allojeneik kök hücre naklinde geç dönem CMV reaktivasyon sıklığı. 5.Febril Nötropeni Simpozyumu, 20-23 Şubat 2003, Antalya. S184 (P-55), 2003. (Poster)
D26. Arat M, Soydan E, Topçuoğlu P, Yüksel MK, Akan H. Allojeneik hematopoetik kök hücre transplantasyonu sonrası kök hücre kaynağı ve hazırlık rejimlerine göre febril nötropnei sıklığı. 5.Febril Nötropeni Simpozyumu, 20-23 Şubat 2003, Antalya. S158 (P-29), 2003. (poster)
D27. Soydan EA, Arat M, Bulakbaşı T, Topçuoğlu P, Arslan Ö, Özcan M, Gürman G, İlhan O. Allojeneik hemapoietik hücre nakli kararı alınan olgularimizin iki yıllık takipleri: nakil hızınınerken dönem nakil başarısına etkisi. XXX. Ulusal Hematoloji Kongresi, 10-14 Ekim 2003, İstanbul. Turk J Haematol 20(3): 52, 2003. (Sözel)
D28. Arat M, Soydan EA, Topçuoğlu P, Aktaş B, Beksaç M. Cinsiyet uyumsuz allojeneik hematopoietik hücre transplantlarda nakil öncesi parite ile graft versus host hastalığı insidansı ilişkisi XXX. Ulusal Hematoloji Kongresi, 10-14 Ekim 2003, İstanbul. Turk J Haematol 20(3): 53, 2003. (Sözel)
D29. Gürman G, Arat M, Topçuoğlu P, Soydan EA; İlhan O, Beksaç M, Özcan M, Konuk N, Koç H, Arslan Ö, Akan H. Kronik myelositer lösemide allojeneik hematopoietik hücre transplantasyonu: standart doz ile indirgenmiş doz hazırlık rejiminin karşılaştırılması. XXX. Ulusal Hematoloji Kongresi, 10-14 Ekim 2003, İstanbul. Turk J Haematol 20(3): 67, 2003. (Sözel)
D30. Beksaç M, Soydan E, Arat M, Topçuoğlu P, Yüksel MK, Toprak SK, Kızıl M, Arslan Ö, Özcan M, Gürman G, İlhan O, Akan H. Multiple Miyelom (MM) olgularında Kök Hücre Desteğinde Yüksek Doz Kemoterapinin, Konvansiyonel Tedavilerle Karşılaştırıldığında Yaşam Süresini Uzattığına Dair Ankara Tıp Fakültesi Hematoloji Bilim Dalı Deneyimi. XXX. Ulusal Hematoloji Kongresi, 10-14 Ekim 2003, İstanbul